Solomon Moshkevich serves as the President of Clinical Diagnostics at Natera, Inc., a leading biotechnology company focused on revolutionizing the diagnosis and management of genetic diseases and cancer. In his role, Moshkevich is responsible for overseeing the development and commercialization of Natera's clinical diagnostic products, which are used by healthcare providers to inform patient care decisions. His leadership has been instrumental in expanding the company's portfolio of innovative tests and driving the adoption of Natera's solutions in clinical settings. Prior to joining Natera, Moshkevich held several senior leadership positions in the life sciences and diagnostics industry. He has a proven track record of successfully launching and scaling diagnostic products, having led the development and commercialization of numerous molecular diagnostic tests throughout his career. Moshkevich's expertise in clinical diagnostics, combined with his strategic vision, has been a key factor in Natera's growth and success in the competitive field of precision medicine. Under Moshkevich's guidance, Natera has continued to advance its mission of making personalized genetic testing accessible to patients worldwide. His leadership has enabled the company to expand its reach and impact, partnering with healthcare providers and research institutions to improve patient outcomes. Moshkevich's dedication to innovation and his commitment to improving healthcare through cutting-edge diagnostics have solidified his reputation as a respected leader in the industry.